I’m sorry if I wasn’t clear. BSL’s equity per share at last report was a bit over $22.
ROE is likely to be around 10% this year.
At the moment the market values that equity at $20.
The implied return to the shareholder is 11% partly as dividend, partly as a further increase in the value of the equity - if the market continues to apply this discount.
Generally speaking, as long as a company is performing ok prices will rise as equity rises. If the company does well the share price will usually be greater than the equity per share. Patience is required.
I have bought BSL a number of times since 2019 always at less than the equity value per share, for instance in 2020 at $8.97 when the equity was about $13/ share. Return since first purchase in 2019 is 23.4% p.a. if sold today.
- Forums
- ASX - By Stock
- BSL
- Ann: BlueScope 2023 US Site Visit Presentation Day 1
Ann: BlueScope 2023 US Site Visit Presentation Day 1, page-27
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$21.82 |
Change
0.240(1.11%) |
Mkt cap ! $9.570B |
Open | High | Low | Value | Volume |
$21.52 | $22.03 | $21.49 | $27.25M | 1.249M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1042 | $21.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.82 | 1256 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1042 | 21.810 |
1 | 4878 | 21.800 |
1 | 1711 | 21.780 |
2 | 6600 | 21.770 |
1 | 1716 | 21.760 |
Price($) | Vol. | No. |
---|---|---|
21.820 | 1256 | 1 |
21.830 | 2304 | 1 |
21.840 | 3508 | 2 |
21.850 | 2398 | 1 |
21.860 | 2247 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
BSL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online